VP API? (Venturepharm API) core competency focuses on its strong R&D capacity, driven by over two hundred chemical elites from all over the world. We are able to offer about 200 bulk active pharmaceutical ingredients and relative key intermediates. We have 4 bulk API manufacturing facilities, two of which are cGMP approved & USFDA inspected.

 

Our expertise in organic synthesis, process development and a controlled supply chain，six Vsmart proprietary NCEs platforms and 20 patents application annually enables us to provide the demanding customers bulk APIs with high quality and competitive price.

 

We are aggressively building our product portfolio to cater to the generic and patent-challenged formulators in regulated markets, and the generic players in emerging markets. Today, Venturepharm API has a world-wide clientele of 60 companies engaging in various kinds of activities including technology licensing and marketing joint venture.

 

With the strong background of R&D capacity and GMP manufacturing facilities, we are also among the largest R&D services providers. The services include: 

 Customer synthesis of milligram to kilogram quantities

 Process research , devel.opment and optimization

 Large scale synthesis and commercial manufacturing

 Analytical services

 Key intermediates production



Claim

(1) Products covered by valid patents are not offered or supplied for commercial use. 



(2) The patents position should be verified by the customer. 



(3) All the products can be supplied for R&D use. 



Address: Venturepharm Towers, N0.3 Jinzhuang, Si Ji Qing, 

              Haidian District,Beijing, 100089, China

Attn: Mr. Daniel

Tel:  +86-10-88500088 Ext. 333

Fax:  +86-10-88500080

E-mail:  apism@venturepharm.net

Website: www.venturepahrm.com